Investing.com - Oppenheimer hat sein Kursziel für die Aktien von Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) von 62 $ auf 72 $ angehoben und die Einstufung "Outperform" beibehalten. Das Analysehau ...

RVPH On behalf of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Chief Executive Officer, Dr. Laxminarayan Bhat, composed a letter to shareholders acknowledging the difficult path over the last ...

Designed for real-world pharmaceutical development, the ED-1 supports automated, 24/7 operation with streamlined data acquisition and high reproducibility. This transforms MicroED from a specialized, ...

From crystallographers' beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why st ...

The stock price of BridgeBio plunged 15% Thursday as Pfizer’s reported decision to withdraw a tafamidis patent in the European Union triggered fears of earlier generic entry in the blockbuster ...

Walmart Media Group (WMG), the retailer’s data-driven advertising business, took another step forward with its in-house advertising program on Thursday with the acquisition of Polymorph Labs, a San ...

What is being hailed as a 'cancer treatment breakthrough' comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms. Researchers from Johns Hopkins University ...

Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...

Experiments conducted onboard the International Space Station have shown that crystals grown in microgravity are often larger and more ordered than those grown on Earth Another promising development ...

Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision signals a change to assessing inventive step in polymorph patents in China On ...